No Life Raft for HIV

Frontlines | No Life Raft for HIV Courtesy of Pagsanjan.org The way to plot a story, goes the old saw, is to put people on a raft in the water and put a hole in it. A similar situation faced HIV-1 researcher Marilyn Resh, but with a twist: She had to knock off the occupants while preserving the raft. These rafts--so named because they are insoluble in nonionic detergent--are domains within a cell membrane. The HIV glycosaminoglycan (Gag) proteins occupy these rafts. To build a new HIV part

Written byMyrna Watanabe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The way to plot a story, goes the old saw, is to put people on a raft in the water and put a hole in it. A similar situation faced HIV-1 researcher Marilyn Resh, but with a twist: She had to knock off the occupants while preserving the raft. These rafts--so named because they are insoluble in nonionic detergent--are domains within a cell membrane. The HIV glycosaminoglycan (Gag) proteins occupy these rafts. To build a new HIV particle, 1,000 to 1,500 Gag molecules from these rafts assemble into a virus-like particle, which is an essential precursor to viral reproduction.

Rafts are believed to "concentrate proteins in a small region of the membrane and thereby make protein-protein interaction more efficient," says Resh, a cell biology professor at Memorial Sloan-Kettering Cancer Center in New York. She doesn't destroy the rafts to prevent Gag attachment, because that could affect healthy cells. Normally, Gag ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies